Philips and Mount Sinai Health System Collaborate to Advance Clinical Research through New Digital Pathology Database and Analytics

PhilipsRoyal Philips (NYSE:PHG, AEX:PHIA) today announced a joint development agreement with the Mount Sinai Health System, an integrated health system in New York, to create a state-of-the-art digital image repository of patient tissue samples and innovative data analytics to pursue the discovery of new tissue-based tests and unlock pathology data. The collaboration aims to advance clinical research and ultimately enable better care for complex diseases, including cancer.

Pathology, including the examination of patient tissue samples, is one of the corner stones of modern medicine. The Mount Sinai Health System comprises seven hospital campuses serving approximately 170,000 inpatients and 2.6 million outpatients annually. Over the years, these sites have collectively stored hundreds of thousands of tissue samples in the form of glass tissue slides. Philips and Mount Sinai will now start to create a comprehensive digital image repository containing the digital scans of all these glass tissue slides. Ultimately, these data will be made accessible to researchers. By integrating, analyzing and presenting the data available from whole slide pathology images, clinical laboratory services, genetic analysis, radiology, and surgical and molecular pathology, Philips and Mount Sinai believe the unique insights obtained will enable the development of predictive analytics to help personalize patient care.

"The digitization of pathology gives us the unprecedented opportunity to access vast amounts of unlocked data and view it within the context of other images, results and clinical information," said Frans van Houten, CEO Royal Philips. "It is our vision that our improved understanding of these data will help us enable better, more individualized care with greater confidence."

"This collaboration with Philips has the potential to help drive a new paradigm in healthcare that includes the optimization of treatment efficacy and superior clinical outcomes," said Dr. Carlos Cordon-Cardo M.D., Ph.D., Chairman of the Department of Pathology at the Mount Sinai Health System. "Our ultimate goal with this initiative is to translate data into knowledge to maximize personalized patient management."

Mount Sinai is committed to partnering with industry to develop innovative therapies and diagnostics that improve the lives of patients worldwide. The terms of this collaboration agreement were managed by Mount Sinai Innovation Partners, the technology development and commercialization group for the Mount Sinai Health System.

Related news articles:

About the Mount Sinai Health System

The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven member hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services - from community-based facilities to tertiary and quaternary care.

The System includes approximately 6,600 primary and specialty care physicians, 12-minority-owned free-standing ambulatory surgery centers, over 45 ambulatory practices throughout the five boroughs of New York City, Westchester, and Long Island, as well as 31 affiliated community health centers. Physicians are affiliated with the Icahn School of Medicine at Mount Sinai, which is ranked among the top 20 medical schools both in National Institutes of Health funding and by U.S. News & World Report.

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2014 sales of EUR 21.4 billion and employs approximately 105,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...